Anti-parkinsonism, hypoglycemic and anti-microbial activities of new poly fused ring heterocyclic candidates

Int J Biol Macromol. 2013 Jun:57:165-73. doi: 10.1016/j.ijbiomac.2013.03.019. Epub 2013 Mar 15.

Abstract

A new series of poly fused pyrazolothienopyrimidine derivatives (2-14) were synthesized and their anti-parkinsonism, hypoglycemic and anti-microbial activities were evaluated. Some of the newly synthesized compounds exhibited better pharmacological and biological activities than the reference controls with low concentrations. The structures of newly synthesized compounds were confirmed by chemical, elemental and spectroscopic evidences. The detailed synthesis, spectroscopic data, and pharmacological activities were reported.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Infective Agents* / chemical synthesis
  • Anti-Infective Agents* / chemistry
  • Anti-Infective Agents* / pharmacology
  • Antiparkinson Agents* / chemical synthesis
  • Antiparkinson Agents* / chemistry
  • Antiparkinson Agents* / pharmacology
  • Aspergillus fumigatus / growth & development*
  • Bacteria / growth & development*
  • Candida albicans / growth & development*
  • Heterocyclic Compounds, 2-Ring* / chemical synthesis
  • Heterocyclic Compounds, 2-Ring* / chemistry
  • Heterocyclic Compounds, 2-Ring* / pharmacology
  • Hypoglycemic Agents* / chemical synthesis
  • Hypoglycemic Agents* / chemistry
  • Hypoglycemic Agents* / pharmacology
  • Mice
  • Parkinson Disease, Secondary / chemically induced
  • Parkinson Disease, Secondary / drug therapy*

Substances

  • Anti-Infective Agents
  • Antiparkinson Agents
  • Heterocyclic Compounds, 2-Ring
  • Hypoglycemic Agents